Login / Signup

On the reporting and analysis of a cancer evolutionary adaptive dosing trial.

Hitesh B Mistry
Published in: Nature communications (2021)
Keyphrases
  • papillary thyroid
  • study protocol
  • clinical trial
  • squamous cell
  • phase iii
  • genome wide
  • phase ii
  • adverse drug
  • randomized controlled trial
  • emergency department